Zealand Pharma A/S (CPH:ZEAL)
Denmark
· Delayed Price · Currency is DKK 234.90
-134.30 (-36.38%)
At close: Mar 6, 2026
Zealand Pharma Market Cap
Zealand Pharma has a market cap or net worth of 16.59 billion as of March 6, 2026. Its market cap has decreased by -70.04% in one year.
Market Cap
16.59B
Enterprise Value
1.88B
Revenue
9.21B
Ranking
n/a
PE Ratio
2.60
Stock Price
234.90
Market Cap Chart
Since November 24, 2010, Zealand Pharma's market cap has increased from 1.41B to 16.59B, an increase of 1,079.86%. That is a compound annual growth rate of 17.52%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,104.89B |
| Genmab | 109.14B |
| Coloplast | 103.96B |
| ALK-Abelló | 49.85B |
| Demant | 39.71B |
| H. Lundbeck | 37.23B |
| Ambu A/S | 20.43B |
| Bavarian Nordic | 14.54B |